nodes	percent_of_prediction	percent_of_DWPC	metapath
Metaraminol—ADRA1A—Adrenoceptors—ADRA2C—attention deficit hyperactivity disorder	0.121	0.141	CbGpPWpGaD
Metaraminol—ADRA1A—Adrenoceptors—ADRA2A—attention deficit hyperactivity disorder	0.0636	0.0742	CbGpPWpGaD
Metaraminol—ADRA1A—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.0428	0.0499	CbGpPWpGaD
Metaraminol—ADRA1A—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.042	0.0489	CbGpPWpGaD
Metaraminol—ADRA1A—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.036	0.042	CbGpPWpGaD
Metaraminol—ADRA1A—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0353	0.0411	CbGpPWpGaD
Metaraminol—ADRA1A—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.0254	0.0296	CbGpPWpGaD
Metaraminol—ADRA1A—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.0245	0.0285	CbGpPWpGaD
Metaraminol—Levonordefrin—ADRA2C—attention deficit hyperactivity disorder	0.0241	0.17	CrCbGaD
Metaraminol—ADRA1A—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.0236	0.0276	CbGpPWpGaD
Metaraminol—ADRA1A—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.0229	0.0267	CbGpPWpGaD
Metaraminol—ADRA1A—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.0225	0.0262	CbGpPWpGaD
Metaraminol—ADRA1A—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.0222	0.0259	CbGpPWpGaD
Metaraminol—ADRA1A—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.0214	0.0249	CbGpPWpGaD
Metaraminol—ADRA1A—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.0207	0.0241	CbGpPWpGaD
Metaraminol—ADRA1A—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.0199	0.0232	CbGpPWpGaD
Metaraminol—ADRA1A—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.0192	0.0224	CbGpPWpGaD
Metaraminol—ADRA1A—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.0189	0.0221	CbGpPWpGaD
Metaraminol—ADRA1A—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.0187	0.0218	CbGpPWpGaD
Metaraminol—ADRA1A—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.0174	0.0203	CbGpPWpGaD
Metaraminol—Droxidopa—ADRA2C—attention deficit hyperactivity disorder	0.017	0.12	CrCbGaD
Metaraminol—ADRA1A—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.0145	0.0169	CbGpPWpGaD
Metaraminol—Phenylephrine—MAOA—attention deficit hyperactivity disorder	0.0141	0.0992	CrCbGaD
Metaraminol—ADRA1A—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.0122	0.0142	CbGpPWpGaD
Metaraminol—Levonordefrin—ADRA2A—attention deficit hyperactivity disorder	0.0103	0.0724	CrCbGaD
Metaraminol—Phenylpropanolamine—MAOA—attention deficit hyperactivity disorder	0.00934	0.0657	CrCbGaD
Metaraminol—Tapentadol—SLC6A4—attention deficit hyperactivity disorder	0.00917	0.0645	CrCbGaD
Metaraminol—Phenylpropanolamine—DRD1—attention deficit hyperactivity disorder	0.0085	0.0598	CrCbGaD
Metaraminol—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00827	0.00964	CbGpPWpGaD
Metaraminol—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.0081	0.00944	CbGpPWpGaD
Metaraminol—ADRA1A—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.0081	0.00944	CbGpPWpGaD
Metaraminol—Phenylpropanolamine—SLC6A3—attention deficit hyperactivity disorder	0.00805	0.0567	CrCbGaD
Metaraminol—ADRA1A—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00804	0.00938	CbGpPWpGaD
Metaraminol—Phenylpropanolamine—ADRA2A—attention deficit hyperactivity disorder	0.00789	0.0555	CrCbGaD
Metaraminol—Pseudoephedrine—MAOA—attention deficit hyperactivity disorder	0.00789	0.0555	CrCbGaD
Metaraminol—Droxidopa—ADRA2A—attention deficit hyperactivity disorder	0.00725	0.051	CrCbGaD
Metaraminol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00708	0.00826	CbGpPWpGaD
Metaraminol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00694	0.00809	CbGpPWpGaD
Metaraminol—Pseudoephedrine—SLC6A3—attention deficit hyperactivity disorder	0.0068	0.0479	CrCbGaD
Metaraminol—Pseudoephedrine—ADRA2A—attention deficit hyperactivity disorder	0.00667	0.0469	CrCbGaD
Metaraminol—ADRA1A—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00562	0.00655	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00539	0.00629	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00529	0.00616	CbGpPWpGaD
Metaraminol—Pseudoephedrine—SLC6A4—attention deficit hyperactivity disorder	0.00509	0.0358	CrCbGaD
Metaraminol—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00491	0.00572	CbGpPWpGaD
Metaraminol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00481	0.00561	CbGpPWpGaD
Metaraminol—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00456	0.00532	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00455	0.0053	CbGpPWpGaD
Metaraminol—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00442	0.00515	CbGpPWpGaD
Metaraminol—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00434	0.00506	CbGpPWpGaD
Metaraminol—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00429	0.005	CbGpPWpGaD
Metaraminol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00421	0.0049	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00413	0.00481	CbGpPWpGaD
Metaraminol—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.004	0.00466	CbGpPWpGaD
Metaraminol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00391	0.00456	CbGpPWpGaD
Metaraminol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00379	0.00441	CbGpPWpGaD
Metaraminol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00372	0.00434	CbGpPWpGaD
Metaraminol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00368	0.00428	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00366	0.00427	CbGpPWpGaD
Metaraminol—ADRA1A—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00362	0.00422	CbGpPWpGaD
Metaraminol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00342	0.00399	CbGpPWpGaD
Metaraminol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00324	0.00378	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.0032	0.00373	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00305	0.00355	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00299	0.00348	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00298	0.00347	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00288	0.00336	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00283	0.0033	CbGpPWpGaD
Metaraminol—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.0028	0.00326	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.0028	0.00326	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00277	0.00323	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00271	0.00316	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00261	0.00304	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00244	0.00284	CbGpPWpGaD
Metaraminol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.0024	0.0028	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00207	0.00241	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.0019	0.00222	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00188	0.00219	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00183	0.00213	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00181	0.00211	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00168	0.00196	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00164	0.00192	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00164	0.00191	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00163	0.0019	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.0016	0.00187	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.0016	0.00187	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00158	0.00184	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00157	0.00183	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00153	0.00178	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00148	0.00172	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00147	0.00172	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00145	0.0017	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00144	0.00167	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00134	0.00156	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00111	0.00129	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00103	0.0012	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000971	0.00113	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000937	0.00109	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000902	0.00105	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000874	0.00102	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000859	0.001	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000849	0.000989	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00079	0.000921	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000554	0.000645	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000293	0.000342	CbGpPWpGaD
